Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/BIOMEA-FUSION-INC-121456063/news/Biomea-Fusion-Inc-gibt-bekannt-dass-der-erste-Patient-in-der-klinischen-Phase-I-Studie-COVALENT-45083527/?utm_source=whatsapp&utm_medium=social&utm_campaign=share